180 related articles for article (PubMed ID: 37937687)
1. Small molecule inhibitors targeting regulatory T cells for cancer treatment.
García-Díaz N; Wei Q; Taskén K
Eur J Immunol; 2024 Feb; 54(2):e2350448. PubMed ID: 37937687
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies.
Nishikawa H; Koyama S
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34330764
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of regulatory T cells in cancer.
Shan F; Somasundaram A; Bruno TC; Workman CJ; Vignali DAA
Trends Cancer; 2022 Nov; 8(11):944-961. PubMed ID: 35853825
[TBL] [Abstract][Full Text] [Related]
4. Understanding and Targeting Human Cancer Regulatory T Cells to Improve Therapy.
Kolb HR; Borcherding N; Zhang W
Adv Exp Med Biol; 2021; 1278():229-256. PubMed ID: 33523451
[TBL] [Abstract][Full Text] [Related]
5. FoxP3
Saleh R; Elkord E
Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
[TBL] [Abstract][Full Text] [Related]
6. Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment.
Yang J; Bae H
Exp Mol Med; 2023 Sep; 55(9):1996-2004. PubMed ID: 37653036
[TBL] [Abstract][Full Text] [Related]
7. Treg-mediated acquired resistance to immune checkpoint inhibitors.
Saleh R; Elkord E
Cancer Lett; 2019 Aug; 457():168-179. PubMed ID: 31078738
[TBL] [Abstract][Full Text] [Related]
8. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells.
Sasidharan Nair V; Elkord E
Immunol Cell Biol; 2018 Jan; 96(1):21-33. PubMed ID: 29359507
[TBL] [Abstract][Full Text] [Related]
9. Modulating Treg stability to improve cancer immunotherapy.
Kang JH; Zappasodi R
Trends Cancer; 2023 Nov; 9(11):911-927. PubMed ID: 37598003
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumor-infiltrating tregs for improved antitumor responses.
Qin D; Zhang Y; Shu P; Lei Y; Li X; Wang Y
Front Immunol; 2024; 15():1325946. PubMed ID: 38500876
[TBL] [Abstract][Full Text] [Related]
11. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.
Alissafi T; Hatzioannou A; Legaki AI; Varveri A; Verginis P
J Autoimmun; 2019 Nov; 104():102310. PubMed ID: 31421963
[TBL] [Abstract][Full Text] [Related]
12. Induced regulatory T cells in inhibitory microenvironments created by cancer.
Whiteside TL
Expert Opin Biol Ther; 2014 Oct; 14(10):1411-25. PubMed ID: 24934899
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Ohue Y; Nishikawa H
Cancer Sci; 2019 Jul; 110(7):2080-2089. PubMed ID: 31102428
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.
Muroyama Y; Nirschl TR; Kochel CM; Lopez-Bujanda Z; Theodros D; Mao W; Carrera-Haro MA; Ghasemzadeh A; Marciscano AE; Velarde E; Tam AJ; Thoburn CJ; Uddin M; Meeker AK; Anders RA; Pardoll DM; Drake CG
Cancer Immunol Res; 2017 Nov; 5(11):992-1004. PubMed ID: 28970196
[TBL] [Abstract][Full Text] [Related]
15. Roles of regulatory T cells in cancer immunity.
Takeuchi Y; Nishikawa H
Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
[TBL] [Abstract][Full Text] [Related]
16. Treg Fragility: A Prerequisite for Effective Antitumor Immunity?
Overacre-Delgoffe AE; Vignali DAA
Cancer Immunol Res; 2018 Aug; 6(8):882-887. PubMed ID: 30068755
[TBL] [Abstract][Full Text] [Related]
17. Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity.
Yan Y; Huang L; Liu Y; Yi M; Chu Q; Jiao D; Wu K
J Hematol Oncol; 2022 Aug; 15(1):104. PubMed ID: 35948909
[TBL] [Abstract][Full Text] [Related]
18. Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy.
Ma Y; Xu X; Wang H; Liu Y; Piao H
Front Immunol; 2023; 14():1228331. PubMed ID: 37671150
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
Wang H; Franco F; Ho PC
Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
[TBL] [Abstract][Full Text] [Related]
20. Expression of costimulatory and inhibitory receptors in FoxP3
Toker A; Ohashi PS
Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]